1 Min Read
Sept 1 (Reuters) -
* Karo Bio says acquires Apropharm AS and Apropharm AB
* Karo Bio says purchase price around 100 million SEK
* Apropharm sales around 50 mln SEK, operating profit 12 mln SEK Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.